H D White. Show Affiliations »
Abstract
Mesh： See more » Cerebrovascular Disorders/etiologyCerebrovascular Disorders/prevention & controlFibrinolytic Agents/pharmacologyHumansMyocardial Infarction/complicationsMyocardial Infarction/drug therapyPlasminogen Activators/pharmacologyRandomized Controlled Trials as TopicRecombinant Proteins/pharmacologyThrombolytic TherapyTissue Plasminogen Activator/pharmacologyUrokinase-Type Plasminogen Activator/pharmacology
Substances： See more » Fibrinolytic AgentsRecombinant ProteinsPlasminogen ActivatorsTissue Plasminogen ActivatorUrokinase-Type Plasminogen Activatorsaruplase
Year: 1998 PMID： 9502625 DOI： 10.1016/s0735-1097(97)00551-2
Source DB: PubMed Journal: J Am Coll Cardiol ISSN： 0735-1097 Impact factor: 24.094